Encompass Health Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.0% | +24.9% | +8.5% | +16.0% | -16.7% | +10.9% | +1.6% | -1.4% | +20.5% | +17.9% | +17.2% | |
| – | +29.7% | +23.6% | +6.5% | +8.7% | +9.5% | +11.1% | +5.6% | -5.1% | +12.4% | +9.4% | +9.4% | |
| – | +9.6% | +4.6% | +74.1% | +80.1% | +33.2% | -74.2% | +11.2% | -11.0% | +73.3% | -4.5% | +17.0% | |
| – | +42.2% | +23.9% | +12.0% | +20.3% | -51.0% | +77.3% | -53.2% | +34.8% | – | – | – | |
| – | – | – | – | – | -491.5% | – | – | – | – | -56.5% | -80.4% | |
| – | -16.7% | +29.6% | +20.7% | +10.4% | +49.4% | +1.0% | +35.0% | +6.0% | -0.2% | +10.2% | +14.6% | |
| – | +28.8% | -78.3% | +16.1% | +49.2% | +54.9% | -38.0% | +63.5% | -5.9% | -3.9% | +8.4% | +16.8% | |
| – | +11.4% | +4.4% | +9.2% | +10.2% | +7.8% | +2.9% | +0.4% | -11.9% | -39.0% | +4.0% | +13.2% | |
| – | +5.1% | +44.8% | -41.9% | +72.2% | -30.0% | -86.7% | +0.0% | +19.7% | +12.3% | +279.3% | +408.0% | |
| – | -44.4% | -19.2% | -35.7% | -84.1% | +2,106.3% | -54.0% | -131.7% | +651.4% | -83.3% | +190.5% | -88.0% | |
| – | +47.4% | -159.6% | -5.7% | -10.8% | – | -402.7% | +64.6% | -39.3% | +35.3% | +67.6% | +31.0% | |
| – | -331.8% | – | – | +20.1% | +56.3% | +479.7% | -226.0% | – | – | -62.8% | -206.9% | |
| – | +27.7% | +22.6% | +2.4% | +19.3% | -53.0% | +28.2% | -44.5% | -26.1% | +120.0% | +34.6% | +21.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.